TrialThe lancet. Diabetes & endocrinology2013

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

Stephen E Gitelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.